|
DAGLA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.18700000000194E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.372400E-04 |
| Normal-vs-Stage2 |
5.77489999999958E-05 |
| Normal-vs-Stage3 |
3.53120000000651E-05 |
| Normal-vs-Stage4 |
1.023350E-03 |
| Stage1-vs-Stage2 |
1.579760E-01 |
| Stage1-vs-Stage3 |
2.180200E-01 |
| Stage1-vs-Stage4 |
9.720200E-01 |
| Stage2-vs-Stage3 |
5.400800E-01 |
| Stage2-vs-Stage4 |
2.846000E-01 |
| Stage3-vs-Stage4 |
4.354200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.70250000000238E-05 |
| Normal-vs-AfricanAmerican |
1.557730E-02 |
| Normal-vs-Asian |
5.158800E-01 |
| Caucasian-vs-AfricanAmerican |
4.100400E-01 |
| Caucasian-vs-Asian |
1.994050E-01 |
| AfricanAmerican-vs-Asian |
5.841800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63107999999745E-05 |
| Normal-vs-Female |
8.766400E-04 |
| Male-vs-Female |
2.439800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.446410E-01 |
| Normal-vs-Age(41-60Yrs) |
7.82630000000228E-05 |
| Normal-vs-Age(61-80Yrs) |
9.98309999999947E-05 |
| Normal-vs-Age(81-100Yrs) |
1.010300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.849000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.201000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.421600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.168400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.486000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.659600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.898300E-02 |
| Normal-vs-Grade 2 |
4.792400E-04 |
| Normal-vs-Grade 3 |
4.08880000000167E-05 |
| Normal-vs-Grade 4 |
4.02350000000551E-05 |
| Grade 1-vs-Grade 2 |
6.348400E-01 |
| Grade 1-vs-Grade 3 |
3.387400E-01 |
| Grade 1-vs-Grade 4 |
1.876150E-01 |
| Grade 2-vs-Grade 3 |
2.102400E-01 |
| Grade 2-vs-Grade 4 |
1.810800E-01 |
| Grade 3-vs-Grade 4 |
8.524000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.70020000000482E-05 |
| Normal-vs-ccB subtype |
5.90179999999663E-05 |
| ccA subtype-vs-ccB subtype |
7.539800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.32390000000082E-05 |
| Normal-vs-N1 |
5.979000E-03 |
| N0-vs-N1 |
3.246800E-01 |
|
|
